Assyro AI

Orange Book product · Brand (NDA)

NATAZIA

DIENOGEST; ESTRADIOL VALERATE

Brand (NDA)NDA 022252RX BAYER HLTHCARE

At a glance

May 06, 2010

Approved

Brand (NDA)

Application

Not listed

TE code

2

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    May 06, 2010

    16 yr 4 mo ago

  2. Patent 8071577 expires

    Listed drug product patent expiration.

    May 13, 2026

    1 mo ago

  3. Today

  4. Patent 8153616 expires

    Listed method-of-use patent (U-1240) expiration.

    Jan 30, 2028

    in 1 yr 8 mo

Pharmaceutical detail

Active ingredient

DIENOGEST; ESTRADIOL VALERATE

Strength

N/A,2MG,3MG,N/A,N/A;3MG,2MG,2MG,1MG,N/A

Dosage form

TABLET

Route

ORAL

TE code

Not listed

Application

NDA 022252

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (2)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
8071577May 13, 20261 mo ago
ProductU-1
8153616Jan 30, 2028in 1 yr 8 mo
U-1240
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.